SureTrader
Nadex Advertisement
Interactive Brokers Advertisement
Home > Boards > US Listed > Medical - Drugs > Supernus Pharmaceuticals (SUPN)

1:21AM Supernus Pharma prices 10 mln share IP0

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
surf1944 Member Profile
 
Followed By 418
Posts 22,627
Boards Moderated 4
Alias Born 09/11/06
160x600 placeholder
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/21/2017 4:09:10 PM
Supernus to Host Second Quarter 2017 Earnings Conference Call "GlobeNewswire Inc." - 7/19/2017 4:05:00 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/14/2017 4:25:21 PM
Confidential Treatment Order (ct Order) "Edgar (US Regulatory)" - 6/30/2017 11:24:52 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/27/2017 4:28:49 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/23/2017 4:42:25 PM
Supernus Announces that its Partner Shire Receives FDA Approval for Mydayis™ for ADHD "GlobeNewswire Inc." - 6/21/2017 12:37:14 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/15/2017 4:44:51 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/15/2017 4:44:25 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/15/2017 4:43:32 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/15/2017 4:43:06 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/15/2017 4:43:06 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/13/2017 4:55:51 PM
Generic Drugs Stock Performance Review -- Ironwood Pharma, Medicines Co., Supernus Pharma, and Pacira Pharma "PR Newswire (US)" - 6/12/2017 6:35:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/5/2017 6:20:29 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/2/2017 4:37:44 PM
Supernus to Present at Jefferies Healthcare Conference "GlobeNewswire Inc." - 6/1/2017 4:22:57 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/25/2017 7:09:32 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/9/2017 5:20:36 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/9/2017 4:39:28 PM
Supernus Announces First Quarter 2017 Financial Results "GlobeNewswire Inc." - 5/9/2017 4:15:00 PM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 4/27/2017 4:41:23 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/26/2017 4:40:17 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/26/2017 4:19:03 PM
Supernus to Host First Quarter 2017 Earnings Conference Call "GlobeNewswire Inc." - 4/26/2017 4:15:00 PM
surf1944   Tuesday, 05/01/12 08:26:57 AM
Re: None
Post # of 128 
1:21AM Supernus Pharma prices 10 mln share IP0 at $5.00 per share, price in-line with expectations (SUPN) :

Supernus Pharmaceuticals (SUPN), a former Shire sub developing improved drug formulations for epilepsy and ADHD, plans to raise $55 million by offering 11.0 million shares at a price of $5.00. Supernus Pharmaceuticals will command a market value of $125 million. The Rockville, MD-based company, which was founded in 2005, plans to list on the NASDAQ under the symbol SUPN. Citi and Piper Jaffray (PJC) are the joint bookrunners on the deal.

http://seekingalpha.com/article/544941-6-ipos-planned-for-this-week?source=yahoo



surf's up......crikey



Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist